Edward V. Colapinto
About
In The Last Decade
Edward V. Colapinto
13 papers receiving 417 citations
Peers
Comparison fields: 5 of 41
- Radiology, Nuclear Medicine and Imaging 252
- Neurology 104
- Oncology 97
- Molecular Biology 90
- Immunology and Allergy 52
Countries citing papers authored by Edward V. Colapinto
This map shows the geographic impact of Edward V. Colapinto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward V. Colapinto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward V. Colapinto more than expected).
Fields of papers citing papers by Edward V. Colapinto
This network shows the impact of papers produced by Edward V. Colapinto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward V. Colapinto. The network helps show where Edward V. Colapinto may publish in the future.
Co-authorship network of co-authors of Edward V. Colapinto
This figure shows the co-authorship network connecting the top 25 collaborators of Edward V. Colapinto. A scholar is included among the top collaborators of Edward V. Colapinto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward V. Colapinto. Edward V. Colapinto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 11 | |
| 3 | 5 | |
| 4 | 21 | |
| 5 | Monoclonal antibody and F(ab')2 fragment delivery to tumor in patients with glioma: comparison of intracarotid and intravenous administration. | 49 |
| 6 | Radioimmunotherapy of intracerebral human glioma xenografts with 131I-labeled F(ab')2 fragments of monoclonal antibody Mel-14. | 22 |
| 7 | Enhanced tumor localization and in vivo stability of a monoclonal antibody radioiodinated using N-succinimidyl 3-(tri-n-butylstannyl)benzoate. | 78 |
| 8 | 18 | |
| 9 | Comparative localization of murine monoclonal antibody Me1-14 F(ab')2 fragment and whole IgG2a in human glioma xenografts. | 40 |
| 10 | 16 | |
| 11 | Therapeutic efficacy of antiglioma mesenchymal extracellular matrix 131I-radiolabeled murine monoclonal antibody in a human glioma xenograft model. | 80 |
| 12 | Treatment of intracranial human glioma xenografts with 131I-labeled anti-tenascin monoclonal antibody 81C6. | 58 |
| 13 | 35 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.